APR 21, 2020 6:28 AM PDT

Skin Deep: Handheld Device Sees the Earliest Signs of Cancer

WRITTEN BY: Tara Fernandez

 

Researchers have developed a handheld device that can image structures under the skin at resolutions 100 times greater than that of X-Rays, computed tomography (CT) and Magnetic Resonance Imaging (MRI).

The device was designed to be portable and easy to use, allowing healthcare personnel to image internal organs directly at a clinic or the patient’s bedside — avoiding the long waits and costs of specialized diagnostic facilities.

This new imaging technology is so sensitive that it can detect some of the earliest cellular abnormalities linked to cancer. This is particularly important for spotting tumors originating in the epithelium, a thin layer of tissue lining organs such as the colon, stomach and skin. Current imaging technologies often fall short when it comes to imaging epithelial tissues as they are unable to reach tissue depths of even a single millimetre.

Known as micro optical coherence tomography, or OCT, this new device relies on the near-infrared spectrum of light that penetrates the human body harmlessly. The device accurately measures the time taken for the emitted light to return after bouncing off internal tissues, allowing it to construct an image of the 3-dimensional structures below the skin.

 

 

Six years in the making, this research was the fruit of a collaborative effort between imaging scientists at Nanyang Technological University, Singapore, Harvard Medical School and the University of Alabama.

Lead researcher, Professor Liu Linbo, said, “Our device is a fraction of the size of existing machines and produces clear, high-resolution images in real-time. It uses light to harmlessly penetrate the skin, and it does not involve specialised lead-shielded X-ray equipment or MRI scanners. It is small enough to be handheld, so images could be captured by the bedside.”

A prototype of the device was trialled at the Renmin Hospital of Wuhan University to validate its use in detecting colon polyps — small clumps of cells that form in the lining of the colon or rectum which can progress into cancer. Colonoscopies are the most sensitive test for colorectal polyps, but are invasive and have to be done under sedation.

When put to the test, the device was able to assess whether polyps were malignant or benign with 95 percent accuracy. Commercialization of this technology could pick up cancerous changes much earlier, vastly improving patient outcomes.

 

Source: Nanyang Technological University.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
DEC 23, 2019
Clinical & Molecular DX
DEC 23, 2019
Long awaited at-home test gives hemophiliacs peace of mind
Haemophilia is a genetically-inherited condition that severely affects an individual’s ability to stop bleeding. B ...
DEC 23, 2019
Technology
DEC 23, 2019
Can Artifical Intelligence Detect Leukemia?
Artificial intelligence has always been a hot topic of discussion in the medical sciences with a whirlwind of applicatio ...
JAN 30, 2020
Genetics & Genomics
JAN 30, 2020
How To Choose The Right DNA Testing Kit For You
One of the most exciting scientific advancements in the past decade, at least in terms of its impact on pop culture, was ...
FEB 07, 2020
Clinical & Molecular DX
FEB 07, 2020
New diagnostic technology uses levitating proteins
Intrinsic biophysical properties of proteins hold valuable clues about how they function and their role in disease. Take ...
MAR 29, 2020
Genetics & Genomics
MAR 29, 2020
Biomarkers That Predict Crohn's Disease Are Identified
A series of studies published in Gastroenterology has outlined new approaches in predicting IBD.
MAY 04, 2020
Immunology
MAY 04, 2020
GeoVax and Sino Bio Collaborate on COVID-19 Vaccine Work
GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and ...
Loading Comments...